lobbying_activities: 1881168

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1881168	755b268c-7ecc-4fc1-9ea1-df7343f7a1c0	Q3	RED+BLUE STRATEGIES	400693064	COHERUS BIOSCIENCES	2016	third_quarter	PHA	H.R. 5054 - Agriculture Appropriations Bill for FY 2017- issues related to finding the Food and Drug Administration's Office of Biosimilars. Education and advocacy related to what elements are necessary to ensure a hospitable environment to grow the new Biosimilars market in the United States and the positive impact these medications will have on drug cost and access.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2016-10-18T10:34:19.890000-04:00